Literature DB >> 1678928

Understanding the decision to take the predictive test for Huntington disease.

G J Meissen1, C A Mastromauro, D K Kiely, D S McNamara, R H Myers.   

Abstract

The predictive test for Huntington disease (HD) has allowed those at risk to determine gene status prior to symptoms. The purpose of this research was to understand the motivation and the anticipated reactions of those requesting the test. Forty persons at 50% risk for HD and 31 companions participated in a structured personal interview as part of the predictive test protocol. Reasons for taking the test centered on the reduction of anxiety and uncertainty associated with being at risk and enhanced planning and decision making. Participants also believed that taking the test would produce more positive than negative outcomes. With a favorable result, most anticipated a reduction of anxiety, a more normal future, and relief knowing their children would be at a very low risk. Most also cited benefits as more likely than consequences with an unfavorable result. Making the most of life, easier planning, and reduced uncertainty were rated as more likely than any of the adverse impacts, including short-term depression and becoming frightened. Almost all participants (95%) said they would rather learn that they have the HD gene than remain at 50% risk. The uncertainty, anxiety, and chronic stress associated with being at risk appears to underlie the motivation of many seeking the predictive test for HD.

Entities:  

Mesh:

Year:  1991        PMID: 1678928     DOI: 10.1002/ajmg.1320390408

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  12 in total

1.  More appreciation of life or regretting the test? Experiences of living as a mutation carrier of Huntington's disease.

Authors:  Anette Hagberg; The-Hung Bui; Elisabeth Winnberg
Journal:  J Genet Couns       Date:  2010-09-28       Impact factor: 2.537

2.  Preparing for presymptomatic DNA testing for early onset Alzheimer's disease/cerebral haemorrhage and hereditary Pick disease.

Authors:  A Tibben; M Stevens; G M de Wert; M F Niermeijer; C M van Duijn; J C van Swieten
Journal:  J Med Genet       Date:  1997-01       Impact factor: 6.318

3.  Presymptomatic genetic testing for hereditary cancer in young adults: a survey of young adults and parents.

Authors:  Lea Godino; Daniela Turchetti; Leigh Jackson; Catherine Hennessy; Heather Skirton
Journal:  Eur J Hum Genet       Date:  2018-10-04       Impact factor: 4.246

4.  Nonparticipation in Huntington's Disease Predictive Testing: Reasons for Caution in Interpreting Findings.

Authors:  J Binedell; J R Soldan
Journal:  J Genet Couns       Date:  1997-12       Impact factor: 2.537

5.  Psychological distress in applicants for predictive DNA testing for autosomal dominant, heritable, late onset disorders. The Rotterdam/Leiden Genetics Workgroup.

Authors:  A C DudokdeWit; A Tibben; H J Duivenvoorden; P G Frets; M W Zoeteweij; M Losekoot; A van Haeringen; M F Niermeijer; J Passchier
Journal:  J Med Genet       Date:  1997-05       Impact factor: 6.318

6.  Factors associated with perceived uncertainty among parents of children with undiagnosed medical conditions.

Authors:  Anne C Madeo; Kathleen E O'Brien; Barbara A Bernhardt; Barbara B Biesecker
Journal:  Am J Med Genet A       Date:  2012-06-18       Impact factor: 2.802

7.  "Nothing is absolute in life": understanding uncertainty in the context of psychiatric genetic counseling from the perspective of those with serious mental illness.

Authors:  Catriona Hippman; Zoe Lohn; Andrea Ringrose; Angela Inglis; Joanna Cheek; Jehannine C Austin
Journal:  J Genet Couns       Date:  2013-04-21       Impact factor: 2.537

8.  Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program.

Authors:  I M van der Steenstraten; A Tibben; R A Roos; J J van de Kamp; M F Niermeijer
Journal:  Am J Hum Genet       Date:  1994-10       Impact factor: 11.025

9.  Genetic counselors' perceived responsibilities regarding reproductive issues for patients at risk for Huntington disease.

Authors:  Karrie A Hines; Patricia McCarthy Veach; Bonnie S LeRoy
Journal:  J Genet Couns       Date:  2009-10-23       Impact factor: 2.537

10.  Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's disease.

Authors:  Michael R Cassidy; J Scott Roberts; Thomas D Bird; Ellen J Steinbart; L Adrienne Cupples; Clara A Chen; Erin Linnenbringer; Robert C Green
Journal:  Alzheimers Dement       Date:  2008-11       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.